Dose
Reps speaker urges Nigerians not to believe conspiracy theories about coronavirus vaccine
The speaker of the house of representatives, Femi Gbajabiamila, has advised Nigerians not to believe conspiracy theories about the COVID-19 vaccines. Many Nigerians are wary about receiving the COVID-19 vaccine amid unverified claims that it contains microchips. Faisal Shuaib, chief executive officer of the National Primary Health Care Development Agency (NPHCDA), had recently dismissed the claims as false. The first shipment of the vaccines– 3.9 million doses– arrived in Nigeria on Tuesday and the first dose of the AstraZeneca vaccine was administered today. Speaking at the national flag-off ceremony for the COVID-19 vaccination in Abuja, Gbajabiamila urged Nigerians to rally behind the federal government to fight the pandemic. He also cautioned against playing politics with the vaccinati...
Coronavirus: Concern grows over potential superspreader event during US Capitol riot
Concerns are mounting about the health of lawmakers and other people in the Capitol last week, after the first member to test positive for the Coronavirus (COVID-19) since Wednesday’s chaos, said she believed she was exposed in a crowded hiding place with hundreds of other legislators. Rep. Bonnie Watson Coleman, D-N.J., tested positive on Monday while experiencing mild symptoms, and said in a statement that she believes she caught the virus from her fellow lawmakers while hunkering down as Capitol Police struggled for hours to contain a Trump-inspired mob attack on the Capitol. Lawmakers were trapped in a room near the Capitol with hundreds of others, in some cases for hours, where at least one person who later tested positive for the coronavirus was present. The Office of the Attending P...
Joe Biden receives second dose of coronavirus vaccine on camera
Joe Biden on Monday received the second dose of the Pfizer/BioNTech Covid-19 vaccine on camera, as part of an effort by the President-elect’s incoming administration to reassure the country of the safety of the vaccines. Biden was administered the shot in his left arm by Ric Cuming, chief nurse executive at ChristianaCare’s Christiana Hospital in Newark, Delaware, according to Biden’s transition team. The President-elect said he would be announcing his plan to “get the entire Covid operation up and running,” including the necessary costs, on Thursday. Biden said he had a meeting with members of his team later Monday afternoon. Biden said he was “not afraid of taking the oath outside,” and that his team has been getting briefed, when asked if he had any fears about taking the oath of office...
Russian coronavirus vaccine trials begin in UAE as cases rise
Abu Dhabi has started Phase III clinical trials of Russia’s experimental COVID-19 vaccine, known as Sputnik V, amid a surge in infections in the United Arab Emirates, Abu Dhabi’s media office said on Thursday. The human trial, announced in October before the recent rise in cases, is initially seeking up to 500 volunteers to be vaccinated at a hospital in the emirate of Abu Dhabi. Two doses of the vaccine will be given, 20 days apart, to volunteers, the statement said. Participants will have to be 18 years or older, have not previously been infected with COVID-19 or participated in other COVID-19 vaccine trials, it said. The UAE is also conducting Phase III trials of a COVID-19 vaccine developed by China National Pharmaceutical Group (Sinopharm). The UAE has approved the vaccine and it is a...
ABC: California nurse tests positive over a week after receiving Pfizer coronavirus vaccine
A 45-year-old nurse in California tested positive for COVID-19 more than a week after receiving Pfizer Inc’s coronavirus vaccine, an ABC News affiliate reported on Tuesday. Matthew W., a nurse at two different local hospitals, said in a Facebook post on December 18 that he had received the Pfizer vaccine, telling the ABC News affiliate that his arm was sore for a day but that he had suffered no other side-effects. Six days later on Christmas Eve, he became sick after working a shift in the COVID-19 unit, the report added. He got the chills and later came down with muscle aches and fatigue. He went to a drive-up hospital testing site and tested positive for COVID-19 the day after Christmas, the report said. Christian Ramers, an infectious disease specialist with Family Health Centers of San...
Official: One million Americans vaccinated against coronavirus
More than a million people have received their first dose of a Covid-19 vaccine in the United States, Centers for Disease Control and Prevention (CDC) director Robert Redfield said Wednesday. “The United States achieved an early but important milestone today — jurisdictions have now reported that more than one million people have received their first dose of Covid-19 vaccine since administration began 10 days ago,” said Redfield. In a call with reporters, Moncef Slaoui, chief advisor of the government’s Operation Warp Speed, said that the objective of immunizing 20 million people this month was “unlikely to be met.” But he said the US was still aiming for 100 million people immunized by the end of the first quarter of 2021, and another 100 million by the second quarter. Three million doses...
Coronavirus vaccine breakthrough raises hopes of rapid global rollout
A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...
Europe to pay less than US for Pfizer COVID-19 vaccine
The European Union has struck a deal to initially pay less for Pfizer’s COVID-19 vaccine candidate than the United States, an EU official told Reuters News Agency as the bloc announced on Wednesday it had secured an agreement for up to 300 million doses. The experimental drug, developed in conjunction with Germany’s BioNTech, is the frontrunner in a global race to produce a vaccine, with interim data released on Monday showing it was more than 90 percent effective at protecting people from COVID-19 in a large-scale clinical trial. Under the EU deal, 27 European countries could buy 200 million doses, and have an option to buy another 100 million. The bloc will pay less than $19.50 per jab, a senior EU official involved in talks with vaccine makers told Reuters, adding that partly reflected ...
- 1
- 2
